Citations

Showing 10 of 108119 citations.

A PROGRAM TO FOSTER ADJUSTMENT IN YOUNG CHILDREN
Roberts, Katherine E., Aldrich, C. Anderson

Mayo Clinic

Pediatrics | December 10, 2021 | Volume: 3 | Issue: 2 | Pages: 195-200

10.1542/peds.3.2.195 Get It

WHEN a child living in Rochester reaches the age of 2½ years a letter is sent to his mother asking her to bring the child in to the office of the Rochester Child Health Institute for a check-up. The letter states that the child will be given a developmental test and instructs the mother to tell her child that he is coming to play with some toys. Both mother and child are thus prepared for a friendly visit and an effort is made to have it be a happy experience for everybody concerned. This test is the first standardized one that is given any of our children, since the age of 2½ years is about the earliest age at which the Revised Stanford-Binet test can be used satisfactorily. The visit at this age is the first routine contact that the parent and child have with the psychologists on the Institute staff, although earlier conferences may be arranged in special cases. We hope by offering a routine psychologic service to all the children in the community that parents will learn that it is just as desirable, helpful and normal for their children to have a psychologic check-up as it is to have a physical check-up. We believe that our results will show that most Rochester parents are developing this attitude. This program was started in July 1946 when the babies born in 1944 began reaching the age of 21/2 years. By July 1948, we will have had two years of experience with this program. From the point of view of cooperation, the results are heartening. The first year, 86% of the children on our list were brought in for a test, and on all but 5% we were able to carry out a fairly satisfactory test. During the first nine months of the second year 92% of the children came and a satisfactory test was completed on all but 4%. This acceptance of the psychologic part of the program is undoubtedly related to the fact that parents have had 2½ years of satisfactory contact with the Institute through the prenatal, neonatal and child health clinics and they think any service offered them is likely to be helpful. Another factor of importance is the routine nature of the test. Everyone in town who has a 2½-year-old—not just parents with dull children, problem children or atypical children of some kind—is invited to come. We find now that, if for some reason we miss a child in this age range, parents call up and ask when their child can come. We are probably justified in our belief that parents who come like the service and tell their friends about it.
THE SPIDER NEVUS IN INFANCY AND CHILDHOOD
Wenzl, James E., Burgert, E. Omer

Mayo Clinic

Pediatrics | December 10, 2021 | Volume: 33 | Issue: 2 | Pages: 227-232

10.1542/peds.33.2.227 Get It

At the Mayo Clinic 711 children, ranging in age from birth to 15 years, were examined for the presence of spider nevi. The children were divided into three groups: normal controls, patients with chronic illness and patients with disease of the central nervous system. In the normal children, the incidence of spider nevi increased rapidly after 2 years of age to reach a plateau at about the time of puberty for both sexes. In children more than 13 years of age the incidence appeared to be decreasing, presumably toward the stated incidence of 12 to 15% in so-called normal adults. In normal children, spider nevi appeared to occur more frequently in pubertal females than in pubertal males. The incidence was increased in both sexes in patients more than 4 years of age with disease of the central nervous system. In patients with chronic illnesses, there was no significant increase in spider nevi, but the ratio of pubertal females to pubertal males was reversed. The anatomic distribution in all groups differed from that of adults, the dorsum of the hands and forearms being the sites of predilection in children. In view of the frequency of these lesions in childhood, it appears that the presence of spider nevi in otherwise healthy children is an insignificant stigma.
Local Recurrence of Melanoma Is Higher After Wide Local Excision Versus Mohs Micrographic Surgery or Staged Excision: A Systematic Review and Meta-analysis
Pride, Renee, Erwin, Patricia J., Brewer, Jerry D., Pride, Renee L. D., Miller, Christopher J. , Murad, M. Hassan

Mayo Clinic

Dermatologic Surgery | December 10, 2021 | Volume: 48 | Issue: 2 | Pages: 164-170

10.1097/dss.0000000000003309 | PMID 34889212 Get It

BACKGROUND Complete removal of melanoma is a primary goal of excision, and local recurrence is one measure to evaluate the efficacy of surgical technique. OBJECTIVE To compare published local recurrence rates for melanoma treated with Mohs micrographic surgery (MMS) or staged excision versus wide local excision (WLE). METHODS AND MATERIALS Search of 6 databases identified comparative and noncomparative studies that reported local recurrence rates after MMS, staged excision, or WLE for melanoma. Random-effects meta-analysis was used to estimate odds ratios and 95% confidence interval (CI) from comparative studies and event rates from noncomparative studies. RESULTS Of the 71 studies included (16,575 patients), 12 were comparative studies (2,683 patients) and 56 were noncomparative studies (13,698 patients). Comparative studies showed increased recurrence after WLE compared with MMS or staged excision (odds ratio [OR], 2.5; 95% CI, 1.4–4.6) and compared with MMS alone (OR, 3.3; 95% CI, 1.8–5.9). Pooled data from comparative and noncomparative studies showed a local recurrence rate of 7% after WLE (95% CI, 5%–11%), 3% after staged excision (95% CI, 2%–4%), and less than 1% after MMS (95% CI, 0%–1%). Statistical heterogeneity was moderate to high. CONCLUSION Local recurrence of melanoma is significantly lower after MMS (<1%) and staged excision (3%) compared with WLE (7%).
Outcomes of Sentinel Lymph Node Biopsy for Primary Cutaneous Squamous Cell Carcinoma of the Head and Neck
Pride, Renee L. D., Lopez, Jonathan J., Brewer, Jerry D., Price, Daniel L., Otley, Clark C., Roenigk, Randall K., Arpey, Christopher J., Baum, Christian L., Pride, Renee L. D., Lopez, Jonathan J., Brewer, Jerry D., Price, Daniel L., Otley, Clark C., Roenigk, Randall K., Arpey, Christopher J., Baum, Christian L.

Mayo Clinic

Dermatologic Surgery | December 10, 2021 | Volume: 48 | Issue: 2 | Pages: 157-161

10.1097/dss.0000000000003304 | PMID 34889209 Get It

BACKGROUND Limited data exist on sentinel lymph node biopsy (SLNB) for cutaneous squamous cell carcinoma (cSCC) of the head and neck. OBJECTIVE To review the results of SLNB for patients with cSCC of the head and neck at the authors’ institution. MATERIALS AND METHODS A retrospective review was completed for patients who underwent SLNB for cSCC of the head and neck over 19 years. Patient demographics, immune status, tumor stage, total patients with positive SLNB, local recurrence, nodal recurrence, in-transit metastasis, and disease-specific death were recorded. RESULTS Sixty patients underwent lymphoscintigraphy, and an SLN was identified in 58 patients. The mean follow-up was 3.2 years (range, 15 days–16 years). Four patients (6.9%) had a positive SLNB. All were Brigham and Women's Hospital (BWH) stage T2b tumors. Three of these patients were immunosuppressed, 3 patients underwent neck dissection, and 2 patients received adjuvant radiation. None developed local or regional recurrence. Of the 53 patients with a negative SLNB, there were 4 local recurrences, 2 in-transit metastases, and no nodal recurrences. CONCLUSION Immunosuppressed patients with tumors BWH stage T2b or greater may be a reasonable cohort to focus future prospective studies on the utility of SLNB in cSCC of the head and neck.
THYROID DISEASE AMONG CHILDREN WITH DOWN'S SYNDROME (MONGOLISM)
Hayles, Alvin B., Hinrichs, Ward L., Tauxe, W. Newlon

Mayo Clinic

Pediatrics | December 10, 2021 | Volume: 36 | Issue: 4 | Pages: 608-614

10.1542/peds.36.4.608 Get It

Observations on two mongoloid children, one having primary hypothyroidism and the other having primary hyperthyroidism, have been reported. Primary hypothyroidism in the mongoloid child, in each of the three cases reported to date, has been associated with uterine bleeding attributed to hormonal overlap in the pituitary feedback mechanism. The significance of this phenomenon is not clean. A total of sixteen cases of mongolism with hyperthyroidism have been described. There is no evidence that altered thyroid function plays a role in the clinical manifestations of mongolism, and significant alteration in thyroid function is uncommon among such patients. Both of the carrier protein systems responded to the stresses of the superimposed disease processes in these mongoloid children as they do in normal children. Specifically, the values for the erythrocytic uptake of 1-I131-triiodothyronine and thyroxine and the triiodothynonine binding capacities (Case 2 only) were all in the expected ranges for both thyroid derangements involved. Similarly, in Case 2, where an iron-deficiency anemia was also present, the increase in the iron binding capacity and presumably in the level of transferrin was on the order of that to be expected for the degree of iron deficiency. The response to stress of both carrier protein systems in Down's Syndrome suggests that protein synthesis of transferrin and TBG is normal.
HORMONE-SECRETING TUMORS OF THE ADRENAL CORTEX IN CHILDREN
Hayles, Alvin B., Hahn, Henry B., Sprague, Randall G., Bahn, Robert C., Priestley, James T.

Mayo Clinic

Pediatrics | December 10, 2021 | Volume: 37 | Issue: 1 | Pages: 19-25

10.1542/peds.37.1.19 Get It

In 12 children with hyperadrenocorticism caused by tumor of the adrenal cortex the most common clinical picture was that of a mixture of adrenogenital and Cushing's syndromes. All tumors were surgically removed; adrenal steroids were used in the preparation of 11 patients for operation. One patient died with extensive metastasis 5 months after operation, while 11 were alive and well 18 months to 29 years after operation. Data from the 12 cases in this series and from those in the literature suggest that the likelihood of metastasis may be correlated with the relation of tumor weight to body weight.
CURRENT CONCEPTS IN PEDIATRIC CARDIOVASCULAR SURGERY
Kirklin, John W.

Mayo Clinic

Pediatrics | December 10, 2021 | Volume: 33 | Issue: 6 | Pages: 995-996

10.1542/peds.33.6.995 Get It

AMONG the many interesting congenital cardiac malformations amenable to surgery today, four will be discussed, namely, coarctation of the aorta, ventricular septal defect, Tetralogy of Fallot, and transposition of the great vessels. Recommendations for surgical therapy are based on the experience at the Mayo Clinic. Coarctation of the aorta continues to be most satisfactorily treated by operation and the hospital mortality risk is extremely low. In general, the optimal age for surgery is about 10 to 12 years. Unusually severe systemic hypertension or cardiac enlargement constitute an indication for somewhat earlier surgery. When infants with isolated coarctation of the aorta show severe cardiac failure, and this certainly occurs although uncommonly, operation should be advised at that age. The risk even then is very low, but few cases may require reoperation at age 12 because of failure of adequate growth of the anastomosis. The indications for repair of ventricular septal defect must take into account the estimated size of the lesion and its hemodynamic effects. Patients with small ventricular septal defects who have normalsized hearts and normal electrocardiograms, that is, those without clinical evidence of significant hemodynamic derangement, are not advised by us to undergo repair of the defect at present. Patients with ventricular septal defect and mild or moderate pulmonary artery hypertension (that is, patients whose pulmonary artery pressure is less than 75% of systemic artery pressure) can be operated upon at essentially no hospital risk. Operation is clearly advisable in all of these patients. Patients with ventricular septal defect who have severe pulmonary artery hypertension associated with a large pulmonary blood flow (and thus with only mild elevation of pulmonary vascular resistance) can be operated upon with a low hospital mortality rate, in the neighborhood of 5%.
CIRCULATORY CHANGES IN THE LUNGS DURING EXERCISE
Shepherd, John T.

Mayo Clinic

Pediatrics | December 10, 2021 | Volume: 32 | Issue: 4 | Pages: 683-690

10.1542/peds.32.4.683 Get It

During exercise the normal pulmonary vessels can accommodate a three to fourfold increase in flow with about a 50 per cent increase in perfusion pressure. There is about a 10 per cent increase in the total volume of blood in the lungs, which may be accounted for mainly by an increase in capillary blood volume. The diffusion capacity is increased, the concentration of red blood cells is increased, and a relatively uniform ventilation-perfusion ratio is achieved throughout the lung.
Percutaneous Image-Guided Ablation of Lung Tumors
Alzubaidi, Sadeer , Liou, Harris , Saini, Gia , Segaran, Nicole , Naidu, Sailendra , Patel, Indravadan , Öklü, Rahmi , Alzubaidi, Sadeer J , Patel, Indravadan J, Oklu, Rahmi , Kriegshauser, J. Scott

Mayo Clinic

Journal of Clinical Medicine | December 10, 2021 | Volume: 10 | Issue: 24 | Pages: 5783

10.3390/jcm10245783 | PMID 34945082 Get It

Tumors of the lung, including primary cancer and metastases, are notoriously common and difficult to treat. Although surgical resection of lung lesions is often indicated, many conditions disqualify patients from being surgical candidates. Percutaneous image-guided lung ablation is a relatively new set of techniques that offers a promising treatment option for a variety of lung tumors. Although there have been no clinical trials to definitively compare its efficacy to those of traditional treatments, lung ablation is widely practiced and generally accepted to be safe and effective. Especially encouraging results have recently emerged for cryoablation, one of the newer ablative techniques. This article reviews the indications, techniques, contraindications, and complications of percutaneous image-guided ablation of lung tumors with special attention to cryoablation and its recent developments in protocol optimization.
Disparities in access to surgery for glioblastoma multiforme at high-volume Commission on Cancer–accredited hospitals in the United States
Zreik, Jad, Kerezoudis, Panagiotis , Chaichana, Kaisorn L. , Chen, Clark C. , Bydon, Mohamad , Brown, Desmond A., Goyal, Anshit , Brown, Desmond , Habermann, Elizabeth B. , Parney, Ian F.

Mayo Clinic

Journal of Neurosurgery | December 10, 2021 | Volume: 137 | Issue: 1 | Pages: 32-41

10.3171/2021.7.jns211307 | PMID 34767534 Get It

OBJECTIVE Although it has been shown that surgery for glioblastoma (GBM) at high-volume facilities (HVFs) may be associated with better postoperative outcomes, the use of such hospitals may not be equally distributed. The authors aimed to evaluate racial and socioeconomic differences in access to surgery for GBM at high-volume Commission on Cancer (CoC)–accredited hospitals. METHODS The National Cancer Database was queried for patients with GBM that was newly diagnosed between 2004 and 2015. Patients who received no surgical intervention or those who received surgical intervention at a site other than the reporting facility were excluded. Annual surgical case volume was calculated for each hospital, with volume ≥ 90th percentile defined as an HVF. Multivariable logistic regression was performed to identify patient-level predictors for undergoing surgery at an HVF. Furthermore, multiple subgroup analyses were performed to determine the adjusted odds ratio of the likelihood of undergoing surgery at an HVF in 2016 as compared to 2004 for each patient subpopulation (by age, race, sex, educational group, etc.). RESULTS A total of 51,859 patients were included, with 10.7% (n = 5562) undergoing surgery at an HVF. On multivariable analysis, Hispanic White patients (OR 0.58, 95% CI 0.49–0.69, p < 0.001) were found to have significantly lower odds of undergoing surgery at an HVF (reference = non-Hispanic White). In addition, patients from a rural residential location (OR 0.55, 95% CI 0.41–0.72, p < 0.001; reference = metropolitan); patients with nonprivate insurance status (Medicare [OR 0.78, 95% CI 0.71–0.86, p < 0.001], Medicaid [OR 0.68, 95% CI 0.60–0.78, p < 0001], other government insurance [OR 0.68, 95% CI 0.52–0.86, p = 0.002], or who were uninsured [OR 0.61, 95% CI 0.51–0.72, p < 0.001]); and lower-income patients ($50,354–$63,332 [OR 0.68, 95% CI 0.63–0.74, p < 0.001], $40,227–$50,353 [OR 0.84, 95% CI 0.76–0.92, p < 0.001]; reference = ≥ $63,333) were also found to be significantly associated with a lower likelihood of surgery at an HVF. Subgroup analyses revealed that elderly patients (age ≥ 65 years), both male and female patients and non-Hispanic White patients, and those with private insurance, Medicare, metropolitan residential location, median zip code–level household income in the first and second quartiles, and educational attainment in the first and third quartiles had increased odds of undergoing surgery at an HVF in 2016 compared to 2004 (all p ≤ 0.05). On the other hand, patients with other governmental insurance, patients with a rural residence, and those from a non-White racial category did not show a significant difference in odds of surgery at an HVF over time (all p > 0.05). CONCLUSIONS The present analysis from the National Cancer Database revealed significant disparities in access to surgery at an HVF for GBM within the United States. Furthermore, there was evidence that these racial and socioeconomic disparities may have widened between 2004 and 2016. The findings should assist health policy makers in the development of strategies for improving access to HVFs for racially and socioeconomically disadvantaged populations.